<DOC>
	<DOCNO>NCT01711281</DOCNO>
	<brief_summary>Heart Failure ( HF ) one frequent diagnose upon hospitalization major cause death . Cardiac resynchronization therapy ( CRT ) use implantable device synchronous bi-ventricular stimulation lead improvement hemodynamic parameter , physical capacity quality life . A continuous measurement left-ventricular volume would provide information heart performance could use heart failure monitor optimization CRT-therapy .</brief_summary>
	<brief_title>Monitoring Hemodynamics Heart Failure Patients Intracardiac Impedance Measurement</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>De novo CRTpatients Planned implantation Lumax 740 HFT device , bipolar LVlead true bipolar RVlead NYHA class II III QRS ≥ 150 m LVEF 15 % 35 % LVEDD ≥ 55 mm Evaluable echo measurement Persistent permanent atrial fibrillation Heart surgery within previous 3 month plan time study participation ; postheart transplantation list heart transplantation Nonambulatory patient Chronic renal dialysis Life expectancy less 1 year due noncardiac disease Age &lt; 18 year and/or limit contractual capability Addiction alcohol , medical drug illegal drug Pregnant breastfeed woman Participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Implantable Cardioverter-Defibrillator</keyword>
	<keyword>Intracardiac Impedance Measurement</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Home Monitoring</keyword>
	<keyword>Reverse Remodeling</keyword>
</DOC>